Drug · DIN 02454548
GRASTOFIL
SINGLE-USE PREFILLED SYRINGE
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since November 28, 2016; first marketed November 28, 2016.
- Drug Identification Number (DIN)
- 02454548
- Company (DIN owner)
- Apotex Inc.Toronto, Ontario, Canada
- Schedule
- Schedule D; Prescription
- Dosage form
- Solution
- Route
- Intravenous; Subcutaneous
- Therapeutic class (ATC)
- Filgrastim L03AA02
- Class
- Human
- Record last updated
- August 10, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| FILGRASTIM | 480 MCG | 0.8 ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- October 7, 2016: NOC 18550Supplement to a New Drug Submission (SNDS) · Addition of a new single dose presentation
Other DINs named GRASTOFIL
- DIN 02441489 · Marketed